Mawdsleys Host Webinar on Named Patient Programmes
Mawdsleys Host Webinar on Named Patient Programmes 14th September 2017

Mawdsleys is hosting a webinar to help people in the healthcare sector and pharmaceutical industry develop a deeper understanding of Named Patient Programmes. Participants of the webinar will hear how named patient programmes can be successfully implemented to treat patients who need a medicine that is not locally available to them.

 

 

Content will be presented by Dr Alain Zeitoun, Mawdsleys’ Named Patient programs Medical and Science Liaison, and Richard Leach, Mawdsleys’ Named Patient Program Manager.

 

 

The webinar will be held on 27th September 2017 at 3PM London / 10AM New York.

 

 

For further information, or to register for the webinar, please click here

 

 

If you would like to speak to somebody at Mawdsleys about Named Patient Programmes please contact info@mawdsleys.co.uk

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-pre-wholesale-to-expand/ thumbnail image Mawdsleys Pre-Wholesale to expand

Coming soon - Mawdsleys' Pre-Wholesale division to open additional site in Yorkshire   To make room for our growing third party logistics service at Mawdsleys Pre Wholesale (MPW), we have just completed the purchase of a brand new 18 acre site in Yorkshire (April 2017).  Work has commenced on phase…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-oncoscience-launch-a-named-patient-program-for-cimaher-nimotuzumab-in-the-uk-and-ireland/ thumbnail image Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.   Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…

Read more